drugset / Trial / NCT05924373

Human Dental Pulp Mesenchymal Stem Cells for the Treatment of Chronic Periodontitis Patients

NCT05924373 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective:To evaluate the efficacy of different administration protocols of human dental pulp mesenchymal stem cells for the treatment of chronic periodontitis patients. The secondary objective:To evaluate the safety of different administration protocols of human dental pulp mesenchymal stem cells for the treatment of chronic periodontitis patients. The exploratory objective:To investigate the effects of human dental pulp mesenchymal stem cells on biomarkers in gingival crevicular fluid in chronic periodontitis patients.

Timeline

Start
2023-11-27
Primary completion
2025-03-07
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Dental Fulp Stem Cells Cell therapy 1e+06 cells Other
Subject Human Dental Fulp Stem Cells Cell therapy 1e+07 cells Other

Indications